These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8664739)

  • 1. Drug users and people with HIV infection need better care in prison.
    Ford C
    BMJ; 1996 Jun; 312(7047):1671. PubMed ID: 8664739
    [No Abstract]   [Full Text] [Related]  

  • 2. Access to harm reduction and HIV-related treatment services inside Indian prisons: experiences of formerly incarcerated injecting drug users.
    Chakrapani V; Kamei R; Kipgen H; Kh JK
    Int J Prison Health; 2013; 9(2):82-91. PubMed ID: 25758440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions to reduce HIV transmission related to injecting drug use in prison.
    Jürgens R; Ball A; Verster A
    Lancet Infect Dis; 2009 Jan; 9(1):57-66. PubMed ID: 19095196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs, HIV, and prisons.
    Farrell M; Strang J
    BMJ; 1991 Jun; 302(6791):1477-8. PubMed ID: 1855010
    [No Abstract]   [Full Text] [Related]  

  • 5. The care of injection-drug users with HIV infection.
    Newman RG
    N Engl J Med; 1994 Dec; 331(26):1773; author reply 1774. PubMed ID: 7984202
    [No Abstract]   [Full Text] [Related]  

  • 6. The care of injection-drug users with HIV infection.
    Selbovitz LG; Zide-Selbovitz L
    N Engl J Med; 1994 Dec; 331(26):1773-4. PubMed ID: 7848484
    [No Abstract]   [Full Text] [Related]  

  • 7. The care of injection-drug users with HIV infection.
    Blansfield HN
    N Engl J Med; 1994 Dec; 331(26):1774. PubMed ID: 7984203
    [No Abstract]   [Full Text] [Related]  

  • 8. People who inject drugs in prison: HIV prevalence, transmission and prevention.
    Dolan K; Moazen B; Noori A; Rahimzadeh S; Farzadfar F; Hariga F
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S12-5. PubMed ID: 25727258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug injection and HIV prevalence in inmates of Glenochil prison.
    Gore SM; Bird AG; Burns SM; Goldberg DJ; Ross AJ; Macgregor J
    BMJ; 1995 Feb; 310(6975):293-6. PubMed ID: 7866170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Issues in the management of prisoners infected with HIV-1: the King's College Hospital HIV prison service retrospective cohort study.
    Edwards S; Tenant-Flowers M; Buggy J; Horne P; Hulme N; Easterbrook P; Taylor C
    BMJ; 2001 Feb; 322(7283):398-9. PubMed ID: 11179158
    [No Abstract]   [Full Text] [Related]  

  • 11. Intersecting epidemics of HIV, HCV, and syphilis among soon-to-be released prisoners in Kyrgyzstan: Implications for prevention and treatment.
    Azbel L; Polonsky M; Wegman M; Shumskaya N; Kurmanalieva A; Asanov A; Wickersham JA; Dvoriak S; Altice FL
    Int J Drug Policy; 2016 Nov; 37():9-20. PubMed ID: 27455177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical care for injection-drug users with human immunodeficiency virus infection.
    O'Connor PG; Selwyn PA; Schottenfeld RS
    N Engl J Med; 1994 Aug; 331(7):450-9. PubMed ID: 8035842
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk behaviours for HIV infection among drug users in prison.
    Carvell AL; Hart GJ
    BMJ; 1990 May; 300(6736):1383-4. PubMed ID: 2372588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HIV risk behavior in prison and factors associated with reincarceration of injection drug users].
    Rotily M; Delorme C; Galinier A; Escaffre N; Moatti JP
    Presse Med; 2000 Sep; 29(28):1549-56. PubMed ID: 11072370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European symposium on AIDS and drug misuse: providing care for HIV-infected drug users. Vienna, 28-30 August, 1990.
    Catalan J; Goos C
    AIDS Care; 1991; 3(2):203-5. PubMed ID: 1678970
    [No Abstract]   [Full Text] [Related]  

  • 16. Overview of harm reduction in prisons in seven European countries.
    Sander G; Scandurra A; Kamenska A; MacNamara C; Kalpaki C; Bessa CF; Laso GN; Parisi G; Varley L; Wolny M; Moudatsou M; Pontes NH; Mannix-McNamara P; Libianchi S; Antypas T
    Harm Reduct J; 2016 Oct; 13(1):28. PubMed ID: 27717368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-morbidities among injecting drug users with HIV in India--challenges in clinical management.
    Sarkar K; Chakrabarti S
    Indian J Med Res; 2008 May; 127(5):428-30. PubMed ID: 18653904
    [No Abstract]   [Full Text] [Related]  

  • 18. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indonesian prisons and HIV: part of the problem, part of the solution?
    Nelwan EJ; Diana A; van Crevel R; Alam NN; Alisjahbana B; Pohan HT; van der Ven A; Djaya I
    Acta Med Indones; 2009 Jul; 41 Suppl 1():52-6. PubMed ID: 19920299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring prison buprenorphine misuse in the United Kingdom: a qualitative study of former prisoners.
    Tompkins CN; Wright NM; Waterman MG; Sheard L
    Int J Prison Health; 2009; 5(2):71-87. PubMed ID: 25759139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.